CoChat

A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment

Lo, Su K., Fleming, Kenneth A., Chapman, Roger W. · 1994 · Journal of Hepatology

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

A specific anti-neutrophil antibody was recently described in primary sclerosing cholangitis and was detected using an indirect immunoalkaline phosphatase method. The present study examined the relationship of this antibody with respect to time, clinical activity, liver biochemistry, histology and ursodeoxycholic acid treatment. Fourteen patients with primary sclerosing cholangitis were followed up at regular intervals for 2 years. Clinical activity, liver biochemistry, histology and anti-neutrophil antibody titre were determined during the study period. A fluctuating course of the anti-neutrophil antibody was noted in both untreated patients and in those who were on ursodeoxycholic acid. This finding will have clinical implications if anti-neutrophil antibody is used to screen for potential primary sclerosing cholangitis in the future. The results suggest that several determinations of the antibody would need to be carried out over a period of time. No correlation was found between the antibody titre, clinical activity, liver biochemistry or histology. Anti-neutrophil antibody in primary sclerosing cholangitis probably has no pathogenic significance and is an epiphenomenon.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0168-8278(05)80604-x

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Research works printed but not linked: 4

  1. Mehal, 1991, Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA-DRw52a allele (letter), N Eng J Med, 325, 1252
  2. Sharma, 1991, Perinuclear anti-neutrophil cytoplasmic antibodies in primary sclerosing cholangitis, Hepatology, 14, 64A
  3. Stiehl, 1989, Treatment of primary sclerosing cholangitis with ursodeoxycholic acid: first results of a controlled study (Abstract), Hepatology, 10, 602
  4. Colombel, 1992, Influence of disease activity on presence of perinuclear antineutrophil cytoplasmic autoantibodies in sera from repeatedly tested patients with ulcerative colitis (Abstract), Gastroenterology, 102, A608

Cited by

See all 50

Metadata

Authors
Lo, S. K., Fleming, K. A., & Chapman, R. W.
Affiliations
John Radcliffe Hospital (GB)
Corresponding author
Chapman, Roger W.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
1994-01
Volume
21
Issue
6
Pages
974-978
ISSN
0168-8278 (ISSN-L)
OpenAlex
W2091476871
Cited by
50
References
20
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2015: 4 · 2012: 1
FWCI
2.04
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
Keywords
primary sclerosing cholangitis, antineutrophil antibodies, ursodeoxycholic acid, disease activity, liver biochemistry, liver histopathology, screening marker
MeSH terms
Adult, Aged, Autoantibodies, Female, Follow-Up Studies, Humans, Immunohistochemistry, Liver, Male, Middle Aged, Ursodeoxycholic Acid, Cholangitis, Sclerosing, Biomarkers, Antibodies, Antineutrophil Cytoplasmic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment. https://app.cochat.ai/papers/10.1016/s0168-8278(05)80604-x
The paper
Lo, S. K., Fleming, K. A., & Chapman, R. W. (1994). A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment. Journal of Hepatology. https://doi.org/10.1016/s0168-8278(05)80604-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.